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Purpose: A larynx squamous cell carcinoma (LSCC) is one
of the most common forms of cancer and may exhibit various
complex karyotypes. Materials and Methods: We used com-
parative genomic hybridization (CGH) to analyze DNA gains
and losses in 15 squamous cell carcinomas that consisted of
4 glottic, 10 supraglottic, and 1 transglottic localization samples.
Results: The majority of the chromosomal alterations detected
were gains: 3 samples of LSCCs revealed high level amplifica-
tion, while 6 samples displayed gains in various chromosomal
regions (17p, 3p, 4p, 5p, 6q, 8p, 9p, 14q, 18p and Xq). One
sample was found to have losses (chromosomes 15q and 22q)
and 5 had normal CGH profiles. Conclusion: Many of these
gained regions (4p, 5p, 8p, 10q, 18q and Xq) were novel sites,
which may harbor oncogene(s) that potentially play an im-
portant role in squamous cell tumorigenesis and progression
at supraglottic localizations.
Key Words: Larynx cancer, squamous cell carcinoma, compa-
rative genomic hybridization, deoxyribonucleic acid
INTRODUCTION
Larynx squamous cell carcinomas (LSCCs) account
for the vast majority of the head and neck squamous
cell carcinomas (HNSCCs), with an occurrence rate
of 0.4% in men and 2.2% in women. As the clinical
outcomes vary greatly among LSCCs, therapeutic
decisions can not be made solely on stage and
histology. The current genetic findings in these
tumors have been observed to be important in
their tumorigenesis and therapeutic decisions. The
certain chromosome changes have been identified
as being shared among HNSCCs, and possible
distinct pathways of tumorigenesis should be
taken into account, as they are a heterogeneous
group of tumors.
1 Of the limited number of
cytogenetic studies on these types of tumor, the
most frequently chromosome aberrations involve
1p, 3p, 3q, 5q, 7p, 9p, 9q, 11p, 11q, 13q, 14q, 15q,
17p and 18q.
2-5 Advanced molecular cytogenetic
techniques (FISH and CGH) applied on fixed
materials have allowed a better understanding of
the genetic changes in HNSCCs.
6-15 Gains in 3q, 5p,
8q and 11q13, and losses in 3p and 9p appeared
as consistent genetic changes, with other certain
chromosomal changes occurring in larynx tumors.
10
Molecular studies revealed allelic imbalances in
chromosome regions with known oncogenes and
tumor suppressor genes, and occur most frequently
at 3p, 5q, 9p, 9q, 11p, 11q, 13q, 17p and 18q.
16-18
Cytogenetic, molecular cytogenetic and molecular
genetic studies are being performed to identify the
genes responsible for larynx tumorigenesis.
Here, the CGH technique was used to analyze
unbalanced chromosomal changes in fifteen cases
with a larynx squamous cell carcinoma, and
previously reported chromosomal alterations were
found as well as those being reported for the first
time.
MATERIALS AND METHODS
Paraffin-embedded archival tumor tissues of 15
randomly selected patients with LSCC (13 male
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and 2 female) were studied. The patients' ages
varied between 40 and 72, all tumors were primary
and none of the patients had received any therapy
prior to sampling. Clinical staging was performed
according to the UICC TNM Staging System (Table
1). Two patients had distant metastases, 4 of the
tumors had glottic, 10 were supraglottic and 1
transglottic locations. Hematoxylin-eosin stained
tissue sections (5 mm) were prepared from each
tumor and the histological diagnosis was confirm-
ed in all cases. For the CGH, genomic DNA was
extracted by proteinase K digestion and phenol-
chloroform extraction. Tumor DNA was labeled
with spectrumGreen-dUTP (Vysis Inc. IL, USA).
Reference DNA was prepared from peripheral
blood lymphocytes of healthy female and male do-
nors, and labeled with spectrumRed-dUTP (Vysis
Inc. IL, USA). Both reference and tumor DNAs
were labeled using degenerate oligonucleotide
primed-PCR (DOP-PCR) using the method des-
cribed by Telenius et al.
19 The DOP-PCR product
was run on a 1.2% agarose gel, with a proper
marker DNA, to obtain a 400-2,000 bp probe frag-
ment size of uniform and intense hybridization.
The CGH was performed, but with modifications
to the standard procedures.
7,20,21 Briefly, labeled
tumor and reference DNAs (500 ng) were mixed
with unlabeled Cot-1 DNA (50 g) in 15 μ mL of
hybridization buffer and hybridized to normal
metaphase preparations for 2 days at 37°C in a
moist chamber. After hybridization, the slides were
washed according to previously described pro-
tocols, and the chromosomes counterstained with
4'-6-diamidino 2-phenylindole (DAPI) in an anti-
fade solution.
7,20,21 The hybridization was an-
alyzed using the PSI (Perceptive Scientific Interna-
tional LTD. UK) digital image software Mac Probe
version 4.0, installed on a Zeiss Axiophot-2 epi-
fluorecence microscope equipped with a cooled
CCD camera (Photometrics LTD, Tucson, AZ,
USA) and a filter system (LEP, Hawthorne, NY,
USA) consisting of a 6 position computerized Ludl
filter wheel. Three fluorochrome (DAPI, Spectrum
Green, and SpectrumRed) images were properly
registered and processed with the PSI workstation
using the Mac Probe Program Version 4.0 software
for pseudocolor display which were used to
visualize the color changes along the metaphase
chromosomes.
For each case, ten metaphases were analyzed for
the chromosomal locations of the DNA sequence
gains and losses. These regions were determined
using green-to-red fluorescence intensity ratio
profiles. Defining the gains and losses of DNA
sequence copy numbers in the tumors were based
on comparison of normal DNAs labeled with two
different colors. The decision limits of the green-to-
red ratios were < 0.8 for a loss of DNA copy num-
ber and > 1.50 for a gain. Control labeling and
hybridizations were performed using nick trans-
lation (Boehringer Mannheim) and cross red/green
labeling of the normal and tumor DNA probes,
respectively. Heterochromatic regions of chromo-
somes 1, 9, 16, 19, Y, and acrocentrics 13, 14 and
15 were excluded from the analysis. Processing and




DNA copy number changes were observed in 10
of the 15 samples (66.6 %), the details of which are
displayed in Table 1 and Fig. 1. The majority of
the chromosomal alterations detected were gains.
Three cases revealed polyploidies, and gains were
detected in various chromosome regions in 6
patients. One patient displayed a whole chromo-
some gain of chromosome 1 along with losses
within 15q and 22q. Some patients had common
regions of DNA amplification (Table 1). The gains
and losses of whole and partial chromosomes for
each case are shown in Fig. 1.
The minimal common regions of gains were
determined in the following chromosomal regions:
3p25-pter. 4p16, 5p15.2-pter, 6q26-qter, 8p23.2-
pter, 9p23-pter, 14q31-qter, 17p13.2, 18p11.31-pter
and Xq27qter. Three of the four samples with
glottic localizations were found to have a normal
CGH profile, whereas one had different gains in
various chromosomal regions. One sample that
had a transglottic localization was also found to
have a normal profile. Losses, including the regions
15q26.1-qter and 22q13-qter, were determined in
the same patient, who was also the youngest (40









Gains and normal Losses
1 M/58 Supraglottic T3N1M0 Polyploidy
2 M/60 Supraglottic T4N0M0 2p25-p26,5p15.2-pter,7q21.3,8p23.2-pter,
9p23-pter,10q26-qter,13q33, 14q32,Xq27-qter
3 M/68 Supraglottic T3N0M0 3p25-pter,4p15.3-pter,5p15.2-pter,17p13.2,
18p11.31-pter,Xq27-qter
4 M/58 Supraglottic T4N1M0 6q26-qter, 17
5 M/40 Supraglottic T4N0M0 1 15q26.1-qter
22q13-qter
6 F/50 Glottic T1N0M0 Normal
7 M/55 Glottic T1N0M0 2q27.2,3p24.3-pter,4p16,6p24-pter,8p23.1-pter,
9p23-pter,12p12-pter,15,17p13.1-pter,18,22
8 M/60 Supraglottic T3N1M0 Normal
9 M/60 Supraglottic T4N1M0 Polyploidy
10 M/57 Supraglottic T3N0M0 1,2,3,4,5,6,8,9,10,11,14,17,19,X
11 M/60 Supraglottic T3N0M0 6q22.1-qter,11p15.4,14q31-qter,18
12 M/64 Supraglottic T3N0M0 Polyploidy
13 M/60 Glottic T2N0M0 Normal
14 M/69 Transglottic T3N1M0 Normal
15 M/72 Glottic T1N0M0 Normal
CGH, comparative genomic hybridization; TNM, tumor node metastasis; M, male F, female.
CGH in SCCs
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Fig. 1. Summary of chromosomal gains and
losses detected by comparative genomic
hybridization in fifteen larynx carcinomas. The
Y chromosome, acrocentric p-arms, and chro-
mosome centromeric heterochromatin regions
were excluded from the analysis. Vertical lines
on the right and left sides of a chromosome
indicate a gain or loss of genetic material,
respectively.Ibrahim Keser, et al.
Yonsei Med J Vol. 49, No. 6, 2008
DISCUSSION
Cytogenetic techniques are accepted as having
certain limitations in detecting genomic changes in
solid tumors. They require cell cultures, which are
technically difficult for such tumors, with the risk
of observing chromosomal alterations not belon-
ging to the original tumor. With respect to this,
molecular cytogenetic techniques have many
advantages over cytogenetic methods in the detec-
tion of chromosomal alterations. Comparing our
results with cytogenetic and molecular cytogenetic
findings on LSCCs revealed some similar and some
different results, some of which corresponded to
regions with known cancer-related genes, as re-
ported in various molecular genetic studies.
22,23
Polyploidies were identified in 3 cases using the
CGH technique. Polyploidy was also reported
cytogenetically in short term cultures from biopsy
specimens,
24 cell lines
25 and in tumor cells by flow
cytometry.
26 Aneuploidy, another sign of genomic
instability in tumors, was observed in some of the
patients in this study along with other chromosome
changes, in the form of whole chromosome gains
(Table 1). Amplification of the 5p15.2-pter, 9p23-
pter and Xq27-qter regions were observed as com-
mon findings in two of fifteen cases. 9p23-pter and
Xq27-qter amplifications have not previously been
reported to occur in LSCCs, while amplification of
a region including 5p12.2-pter was reported in a
CGH study in 2 out of 38 cases of primary LSCCs.
9
The 5p15.2-pter region lies within 5p14-pter, am-
plification of which has previously been reported
in 2 out of 23 having primary larynx tumors with
metastases to adjacent lymph nodes.
25 However,
two of our three cases with a polyploidy profile
had metastases, whereas two with 5p15.2-pter had
no distant metastases. With an increased number
of cases, the relation between these findings and
metastases may be revealed. These regions may
gain significance if recurrently reported as putative
oncogene-harboring regions in future studies.
Some of the amplified regions found in our study,
all of which were detected in 1 out of 15 cases, had
been previously reported by other researchers.
7q21.3 and 13q33 lie within the 7q21-q22 and
13q32-qter regions, respectively, the amplifications
of which have been reported by other groups in
SCCs of the head and neck were detected in 6 out
of 43 and 1 out of 13 cases studied, respectively.
27-29
Gain of 13q33 has been previously reported as an
amplification of 13q32-34, which harbors the gene
coding for FGF14 (Fibroblast Growth Factor-14).
Amplification in the 12p12-pter and 14q32 regions
were detected in our study, as well as in 4 out of
43 and 1 out of 30 cases, respectively, in the studies
of Bockmuhl, Brzoska and Speicher.
27-29 There are
no oncogenes in these regions known to be acti-
vated by amplification. The 18p11.31-pter region is
included within 18p, which is known to harbor the
YES1 oncogene, and was reported, by Hermsen et
al, to be amplified.
10 Overexpression of the latter
two regions may play a role in the tumorigenesis
of LSCCs. Some of the regions detected as ampli-
fied in our study have not been previously reported:
2p25-p26, 8p23.2-pter, 10q26-qter, 14q32, Xq27-qter,
3p25-pter, 4p15.3-pter, 17p13.2, 6q26-qter, 2q27.2,
3p24.3, 4p16, 6p24-pter, 8q23.1-pter, 17p13.1-pter,
6q22.1-qter, 11p15.4 and 14q31-qter. This suggests
that these regions may harbor oncogenes which
potentially play an important role in tumorigenesis
and progression of LSCCs. Losses of 15q26.1-qter
and 22q13-qter, which occurred in only 1 patient
in our study, have not frequently been reported
in the literature.
9,10 The FES protooncogene was
localized to the 15q26.1 chromosome region, and
the NBK/ BIK gene, a proapoptotic BCL-2 family
member which is considered a putative tumor
suppressor gene, was mapped to the 22q13 region.
30
The losses occurring in the youngest patient (40
years of age) were noteworthy, suggesting a pos-
sible role in the earlier stages of LSCC develop-
ment. These findings may be rendered significant
if observed in more than one case when a greater
number of cases are studied.
Five of our 15 cases were found to have normal
CGH profiles. The cell tumorigenesis and tumor
progression of these cases may have been due to
point mutations in proto-oncogene(s) and balanced
chromosomal exchanges unable to be detected by
CGH and may also have an effect on these genes.
Although it is well recognized that each tumor
may have its unique genomic alterations, studies
aiming to reveal common recurrent genetic changes
in laryngeal cancers, as in any type of tumor, will
contribute to the collection of useful data, which
eventually can be used for the correlation of ge-
nomic abnormalities with clinical outcome.CGH in SCCs
Yonsei Med J Vol. 49, No. 6, 2008
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